Amicus Therapeutics (FOLD) Tops Q1 EPS by 4c ; Provides Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Amicus Therapeutics (FOLD) Tops Q1 EPS by 4c ; Provides Outlook

Amicus Therapeutics (FOLD) PT Lowered to $13 at BofA Securities

May 10, 2024 5:27 AM EDT

BofA Securities analyst Tazeen Ahmad lowered the price target on Amicus Therapeutics (NASDAQ: FOLD) to $13.00 (from $14.00) while maintaining a Buy rating.

The analyst comments "FOLD reported 1Q Pombiliti+Opfolda (P&O) sales of $11mn and provided FY24 sales guidance of $62-67mn.... More

Amicus Therapeutics (FOLD) PT Lowered to $19 at Morgan Stanley

May 9, 2024 12:03 PM EDT

Morgan Stanley analyst Jeffrey Hung lowered the price target on Amicus Therapeutics (NASDAQ: FOLD) to $19.00 (from $20.00) while maintaining a Underweight rating.

The analyst comments "1Q earnings were in line with Street expectations for Galafold and below on Pombiliti + Opfolda (P+O). The company... More